EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner

Dorottya Ádám iD, József Arany iD, Kinga Fanni Tóth iD, Orsolya Pető iD, Tamara Nyitrai iD, Balázs István Tóth iD, Szilárd Póliska iD, Christos C Zouboulis iD, Attila Oláh iD

Experimental Dermatology · 2025

DOI: 10.1111/exd.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Dorottya Ádám und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Hauptthemen laut MEDLINE: TRPM Cation Channels, Sebaceous Glands, Lipogenesis, Organophosphorus Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Debreceni Egyetem, Magyar Tudományos Akadémia, Kulturális és Innovációs Minisztérium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transient receptor potential melastatin 5 (TRPM5) ion channel is expressed in human hair follicles, where its spontaneous activity contributes to the maintenance of the growing, anagen phase of the hair cycle. Because adjacent sebaceous glands also exhibited TRPM5 immunopositivity, topically applied TRPM5 modulators administered to influence hair growth may also affect sebaceous glands. Hence, we aimed to assess expression of TRPM5 as well as effects of TRPM5 modulators [activators: 2,5‐dimethylpyrazine, 2‐heptanone; antagonist: triphenylphosphine oxide (TPPO)] on human SZ95 sebocytes, i.e., on the best available in vitro model to study human sebaceous glands. First, using complementary methods [RNA‐Seq, RT‐qPCR, western blot, siRNA‐mediated gene silencing and fluorescent Na + ‐ (SBFI AM) and Ca 2+ ‐measurements (Fura‐2 AM)], we found that TRPM5 is not expressed in human sebocytes in a functionally active form. Importantly, while non‐cytotoxic (MTT‐assay) concentrations of the activators were ineffective, TPPO promoted sebaceous lipogenesis (Nile Red labelling). This effect was TRPM5‐independent and was found to be mediated in an Akt‐ and epidermal growth factor receptor (EGFR)‐dependent manner, most likely via the Akt‐induced up‐regulation of diacylglycerol O‐acyltransferase (DGAT)‐2. Moreover, TPPO up‐regulated interleukin (IL)‐6 in an EGFR‐ and p38α MAPK‐dependent manner (RT‐qPCR), whereas it decreased the release of IL‐8 (ELISA), and down‐regulated additional pro‐inflammatory cytokines [chemokine (C‐X‐C motif) ligand [CXCL]‐1, CXCL2, CXCL6, colony‐stimulating factor 2, IL‐32; RNA‐Seq]. Collectively, specific TRPM5 modulators are unlikely to exert direct sebaceous gland‐related side effects, while safe TPPO analogues may induce beneficial moderate lipogenic and anti‐inflammatory effects in dry skin dermatoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPM Cation ChannelsSebaceous GlandsLipogenesisOrganophosphorus CompoundsHumansCell LineInterleukin-8ErbB Receptors

Stichwörter der Autor:innen

TPPOacnedry skininflammationsebocytesebum

Substanzen

TRPM Cation ChannelsTRPM5 protein, humanOrganophosphorus CompoundsInterleukin-8ErbB Receptors

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Doctoral School of Molecular Medicine, University of Debrecen, Debrecen, Hungary.
  • Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
  • Genomic Medicine and Bioinformatics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.

ORCID-Profile: Dorottya Ádám, József Arany, Kinga Fanni Tóth, Orsolya Pető, Tamara Nyitrai, Balázs István Tóth, Szilárd Póliska, Christos C Zouboulis, Attila Oláh

Förderung

  • Debreceni Egyetem
  • Magyar Tudományos Akadémia
  • Kulturális és Innovációs Minisztérium
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Zitieren

APA

Ádám, D., Arany, J., Tóth, K. F., Pető, O., Nyitrai, T., Tóth, B. I., Póliska, S., Zouboulis, C. C., & Oláh, A. (2025). The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner. Experimental Dermatology. https://doi.org/10.1111/exd.70115

Vancouver

Ádám D, Arany J, Tóth KF, Pető O, Nyitrai T, Tóth BI, et al. The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner. Experimental Dermatology. 2025. doi:10.1111/exd.70115

BibTeX
@article{dm2025,
  author = {Ádám, Dorottya and Arany, József and Tóth, Kinga Fanni and Pető, Orsolya and Nyitrai, Tamara and Tóth, Balázs István and Póliska, Szilárd and Zouboulis, Christos C and Oláh, Attila},
  title = {The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70115}
}
Kostenlos starten →